Sustained mesenchymal reprogramming of endothelial cells after completion of chemotherapy
Kass Sjostrom, Shixin Tao, Melissa S. Cobb, Shannon Landers, Amy Kwok, Ria Singh, Ralph V. Shohet, Nataliya Kibiryeva, Eugene A. Konorev · 2025
Read Sustained mesenchymal reprogramming of endothelial cells after completion of chemotherapy by Kass Sjostrom, Shixin Tao, Melissa S. Cobb, Shannon Landers, Amy Kwok, Ria Singh, Ralph V. Shohet, Nataliya Kibiryeva, Eugene A. Konorev (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751855.txt.
Description
Kass Sjostrom and colleagues published a 2025 study on lasting damage from chemotherapy. Heart disease is the top killer of cancer survivors. The drug doxorubicin harms blood vessels and the heart. Damage often keeps growing after treatment ends. The team studied vessel lining cells after the drug was removed.
Even after washout, the cells stayed changed. They switched on growth signals tied to scarring. They also began acting like muscle and scar tissue cells. Heart vessel samples showed the same pattern. The work helps explain delayed heart failure. It also points to signals that future drugs might block.
Catalog record
| CREATOR | Kass Sjostrom, Shixin Tao, Melissa S. Cobb, Shannon Landers, Amy Kwok, Ria Singh, Ralph V. Shohet, Nataliya Kibiryeva, Eugene A. Konorev |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |